Filter the latest scan's published facts — sector, size, yield, valuation — or rank them with a preset: cheapest, fastest growing, most profitable. Every view shows what is in the filings and prices; none ranks opportunity. The model behind the statuses showed no predictive power, and nothing here is a recommendation.
Scan of 2026-06-30 · 2,450 names scored · prices as of that date
Lowest valid-in-sector trailing valuation multiples today, latest scan: each name's sector percentiles on earnings yield, FCF yield, P/S, P/B, P/TBV and P/CFO, averaged (only the metrics valid in its sector — a REIT is never ranked by GAAP P/E here). “Cheapest” is a fact about trailing multiples versus sector peers, not a forecast that they re-rate.
Tested the unforgiving way: a composite ranking built from these same point-in-time filings (2017-01-31 to 2026-05-29) showed no measurable predictive power (mean IC 0.0168, t = 1.21), and its top quintile did not beat holding everything even before costs. Ranks like these describe today's record; they do not predict tomorrow's return.
2,412 names — page 35 of 49 · Export CSV
| # | Ticker | Company | Sector | Cheap composite | P/E (trailing) | P/S (trailing) | FCF yield | Own 5y |
|---|---|---|---|---|---|---|---|---|
| 1701 | ILMN | Illumina Inc | Healthcare | 36.7 | 31.6×FY | 6.2× |
Never the absolute multiple alone. A P/E of 9 is a fact; whether it is low depends on what you hold it against.
The five-year window is the empirically privileged one. Cheap against its sector and cheap against its own history are different claims, and a stock can be one without being the other — which is the whole reason both columns are shown rather than blended into a single score.
| 3.5%FY |
| +0.9σ |
| 1702 | ELMD | Electromed, Inc. | Healthcare | 36.7 | 38.9× | 5.1× | 2.5% | +0.2σ |
| 1703 | VCYT | Veracyte, Inc. | Healthcare | 36.7 | 70.2×FY | 9.0×FY | 2.7%FY | +1.0σ |
| 1704 | LGND | Ligand Pharmaceuticals Inc. | Pharma & chemicals | 36.7 | 50.2×FY | 23.3×FY | 0.8%FY | −1.1σ |
| 1705 | VLO | Valero Energy Corporation | Energy | 36.7 | 34.3×FY | 0.7×FY | 7.2%FY | −0.9σ |
| 1706 | GTY | Getty Realty Corp. | Real estate | 36.7 | n/a — masked | 9.0×FY | 6.4%FY | −0.4σ |
| 1707 | VMC | Vulcan Materials Company(Holding Company) | Materials | 36.7 | 35.8×FY | 4.9×FY | 2.9%FY | +1.1σ |
| 1708 | CHPT | ChargePoint Holdings, Inc. | Other | 36.7 | — | 0.3× | -90.9% | −1.8σ |
| 1709 | HR | Healthcare Realty Trust Incorporated | Real estate | 36.6 | n/a — masked | 251×FY | 6.4%FY | +0.2σ |
| 1710 | CBIO | Crescent Biopharma, Inc. Common Stock | Pharma & chemicals | 36.6 | — | 45.7×FY | -14.6%FY | +0.9σ |
| 1711 | ARMK | ARAMARK | Retail | 36.6 | 47.2× | 0.8× | — | −0.0σ |
| 1712 | FIVE | Five Below, Inc. Common Stock | Retail | 36.6 | 27.7×FY | 2.1×FY | 4.1%FY | +2.3σ |
| 1713 | PEP | PepsiCo, Inc. | Consumer goods | 36.5 | 22.5×FY | 2.0×FY | 4.1%FY | +1.8σ |
| 1714 | NDSN | Nordson Corp | Industrials | 36.5 | 32.6× | 6.0× | 3.8% | −0.2σ |
| 1715 | BOW | Bowhead Specialty Holdings Inc. | Insurance | 36.5 | 18.2×FY | n/a — masked | n/a — masked | — |
| 1716 | ZYME | Zymeworks Inc. | Pharma & chemicals | 36.4 | — | 18.4×FY | -1.8%FY | −0.2σ |
| 1717 | DNTH | Dianthus Therapeutics, Inc. Common Stock | Pharma & chemicals | 36.4 | — | — | -3.1%FY | +0.7σ |
| 1718 | SLDB | Solid Biosciences Inc. Common Stock | Pharma & chemicals | 36.4 | — | — | -20.0%FY | +0.9σ |
| 1719 | SMA | SmartStop Self Storage REIT, Inc. | Real estate | 36.4 | n/a — masked | 6.4×FY | 4.7%FY | — |
| 1720 | PRTA | Prothena Corporation plc Ordinary Shares | Pharma & chemicals | 36.3 | — | 54.4×FY | -31.0%FY | −1.4σ |
| 1721 | KRYS | Krystal Biotech, Inc. Common Stock | Pharma & chemicals | 36.3 | 53.0×FY | 27.9×FY | 1.7%FY | +1.1σ |
| 1722 | XOMA | XOMA Royalty Corporation Common Stock | Pharma & chemicals | 36.3 | 15.9×FY | 48.7×FY | 0.6%FY | +0.2σ |
| 1723 | KYMR | Kymera Therapeutics, Inc. Common Stock | Pharma & chemicals | 36.3 | — | 238×FY | -2.5%FY | +0.8σ |
| 1724 | WWD | Woodward, Inc. | Technology | 36.3 | 51.8× | 6.7× | 1.6% | −1.0σ |
| 1725 | IDXX | Idexx Laboratories Inc | Pharma & chemicals | 36.2 | 39.6×FY | 9.8×FY | 2.5%FY | +1.8σ |
| 1726 | ULCC | Frontier Group Holdings, Inc. Common Stock | Transport | 36.1 | — | 0.5×FY | -33.1%FY | −0.9σ |
| 1727 | EWTX | Edgewise Therapeutics, Inc. Common Stock | Pharma & chemicals | 36.1 | — | — | -3.3%FY | +1.1σ |
| 1728 | EEFT | Euronet Worldwide Inc | Banks | 36.1 | 9.3×FY | n/a — masked | n/a — masked | −0.8σ |
| 1729 | NVCR | NovoCure Limited Ordinary Shares | Healthcare | 36.1 | — | 2.6×FY | -4.4%FY | −0.7σ |
| 1730 | IMNM | Immunome, Inc. | Pharma & chemicals | 36.0 | — | 345×FY | -8.4%FY | +0.4σ |
| 1731 | AMAL | Amalgamated Financial Corp. Common Stock (DE) | Banks | 36.0 | 13.1×FY | n/a — masked | n/a — masked | +2.0σ |
| 1732 | CLB | Core Laboratories Inc. | Energy | 36.0 | 18.1×FY | 1.0×FY | 4.8%FY | — |
| 1733 | HCKT | Hackett Group Inc (The). | Services | 36.0 | 51.5×FY | 2.2×FY | 4.9%FY | +2.3σ |
| 1734 | UHT | Universal Health Realty Income Trust | Real estate | 36.0 | n/a — masked | 6.1×FY | 6.8%FY | +0.8σ |
| 1735 | SERV | Serve Robotics Inc. Common Stock | Industrials | 36.0 | — | 185×FY | -23.9%FY | — |
| 1736 | IVT | InvenTrust Properties Corp. | Real estate | 35.9 | n/a — masked | 9.2×FY | 5.7%FY | −0.7σ |
| 1737 | APGE | Apogee Therapeutics, Inc. Common Stock | Pharma & chemicals | 35.9 | — | — | -2.6%FY | — |
| 1738 | EXTR | Extreme Networks | Technology | 35.9 | 475× | 3.6× | 2.1% | −0.8σ |
| 1739 | WY | Weyerhaeuser Company | Real estate | 35.9 | n/a — masked | 2.5×FY | 3.3%FY | −1.4σ |
| 1740 | GTLS | Chart Industries, Inc. | Industrials | 35.8 | 249×FY | 2.4×FY | 2.0%FY | +0.4σ |
| 1741 | YOU | Clear Secure, Inc. | Technology | 35.8 | 68.0×FY | 8.2×FY | 4.6%FY | −0.3σ |
| 1742 | MRVI | Maravai LifeSciences Holdings, Inc. Class A Common Stock | Pharma & chemicals | 35.7 | — | 8.6×FY | -4.4%FY | −0.9σ |
| 1743 | FENC | Fennec Pharmaceuticals Inc. Common Stock | Pharma & chemicals | 35.7 | — | 8.2×FY | -3.4%FY | −0.0σ |
| 1744 | STAG | STAG INDUSTRIAL, INC. | Real estate | 35.7 | n/a — masked | 8.4×FY | 6.5%FY | +0.6σ |
| 1745 | WT | WisdomTree, Inc. | Brokers & exchanges | 35.7 | 21.8×FY | 4.8×FY | n/a — masked | −0.0σ |
| 1746 | NTLA | Intellia Therapeutics, Inc | Pharma & chemicals | 35.7 | — | 29.1×FY | -20.1%FY | −0.2σ |
| 1747 | SHOO | Steven Madden Ltd | Consumer goods | 35.6 | — | 1.2×FY | 3.9%FY | −0.9σ |
| 1748 | SO | The Southern Company | Utilities | 35.6 | 24.7×FY | 3.6×FY | -2.7%FY | −1.0σ |
| 1749 | BRKR | Bruker Corporation | Healthcare | 35.6 | — | 2.7×FY | 0.5%FY | −2.3σ |
| 1750 | PRAX | Praxis Precision Medicines, Inc. Common Stock | Pharma & chemicals | 35.5 | — | — | -3.0%FY | +0.6σ |
"Cheap composite" is a 0–100 position among valid sector peers — the mean of the component metrics' sector percentiles. "—" means the scan published no figure, deliberately. "n/a — masked" means the metric is misleading in that name's sector (a REIT's GAAP P/E, a bank's FCF yield) — hover for the reason, which comes from the same sector-validity rules the composite itself respects. An FY tag marks a trailing-year figure built from an annual filing; hover for what that means.